Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites-Reference-Cited by-同舟云学术

Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites

Published:2019-01 Issue: Volume:38 Page:S75-S92
ISSN:0277-1691
Container-title:International Journal of Gynecological Pathology
language:en
Short-container-title:International Journal of Gynecological Pathology

Author:

Stewart Colin J.R.,Crum Christopher P.,McCluggage W. Glenn,Park Kay J.,Rutgers Joanne K.,Oliva Esther,Malpica Anais,Parkash Vinita,Matias-Guiu Xavier,Ronnett Brigitte M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology,Pathology and Forensic Medicine

Reference94 articles.

1. Endocervical Adenocarcinomas With Prominent Endometrial or Endomyometrial Involvement Simulating Primary Endometrial Carcinomas

2. Hormone Receptor Immunohistochemistry and Human Papillomavirus In Situ Hybridization Are Useful for Distinguishing Endocervical and Endometrial Adenocarcinomas

3. Distinction of Endocervical and Endometrial Adenocarcinomas

4. A Panel of 3 Markers Including p16, ProExC, or HPV ISH is Optimal for Distinguishing Between Primary Endometrial and Endocervical Adenocarcinomas

5. Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical Adenocarcinomas

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synchronous primary endometrial adenocarcinoma and primary squamous cell carcinoma of the cervix: A case report and literature review;Case Reports in Women's Health;2024-10

2. Possibilities and limitations of magnetic resonance imaging in the diagnostics of endocervical adenocarcinomas;Digital Diagnostics;2024-09-11

3. 2023 FIGO staging system for endometrial cancer: The evolution of the revolution;Gynecologic Oncology;2024-05

4. Staging by imaging in gynecologic cancer and the role of ultrasound: an update of European joint consensus statements;International Journal of Gynecologic Cancer;2024-03

5. Ovarian Endometrioid and Clear-Cell Tumors;Gynecologic and Obstetric Pathology;2024